Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann-Erick Claessens

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Critical Care (London, England)|February 27, 2008
Diagnosis and treatment of severe sepsisYann-Erick Claessens, Jean-François Dhainaut
Cardiovascular & Hematological Disorders Drug Targets|September 11, 2008
Extra-hematopoietic effects of erythropoietinAlain Cariou, Stéphanie André, Yann-Erick Claessens
Critical Care Medicine|May 1, 2004
Protein C/activated protein C pathway: overview of clinical trial results in severe sepsisJean-François Dhainaut, S Betty Yan, Yann-Erick Claessens
Critical Care (London, England)|February 21, 2004
Unprecedented heat-related deaths during the 2003 heat wave in Paris: consequences on emergency departmentsJean-François Dhainaut, Yann-Erick Claessens, Christine Ginsburg, et al.
Critical Care Medicine|December 24, 2008
Beyond clinical phenotype: the biologic integratomeDavid Grimaldi, Yann-Erick Claessens, Jean-Paul Mira, et al.
Critical Care (London, England)|June 10, 2003
Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitorsYann-Erick Claessens, Jean-Daniel Chiche, Jean-Paul Mira, et al.
Critical Care (London, England)|May 28, 2013
Are clinical trials dealing with severe infection fitting routine practices? Insights from a large registryYann-Erick Claessens, Philippe Aegerter, Hamdi Boubaker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2005
Underlying disorders and their impact on the host response to infectionJean-Francois Dhainaut, Yann-Erick Claessens, Jonathan Janes, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|May 9, 2006
Life-threatening hemophagocytic syndrome related to mycobacterium tuberculosisYann-Erick Claessens, Frédéric Pene, Micheline Tulliez, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 1, 2013
Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values?Camille Chenevier-Gobeaux, Eloise Trabattoni, Marie Roelens, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Critical Care (London, England)|February 27, 2008
Diagnosis and treatment of severe sepsisYann-Erick Claessens, Jean-François Dhainaut
Cardiovascular & Hematological Disorders Drug Targets|September 11, 2008
Extra-hematopoietic effects of erythropoietinAlain Cariou, Stéphanie André, Yann-Erick Claessens
Critical Care Medicine|May 1, 2004
Protein C/activated protein C pathway: overview of clinical trial results in severe sepsisJean-François Dhainaut, S Betty Yan, Yann-Erick Claessens
Critical Care (London, England)|February 21, 2004
Unprecedented heat-related deaths during the 2003 heat wave in Paris: consequences on emergency departmentsJean-François Dhainaut, Yann-Erick Claessens, Christine Ginsburg, et al.
Critical Care Medicine|December 24, 2008
Beyond clinical phenotype: the biologic integratomeDavid Grimaldi, Yann-Erick Claessens, Jean-Paul Mira, et al.
Critical Care (London, England)|June 10, 2003
Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitorsYann-Erick Claessens, Jean-Daniel Chiche, Jean-Paul Mira, et al.
Critical Care (London, England)|May 28, 2013
Are clinical trials dealing with severe infection fitting routine practices? Insights from a large registryYann-Erick Claessens, Philippe Aegerter, Hamdi Boubaker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2005
Underlying disorders and their impact on the host response to infectionJean-Francois Dhainaut, Yann-Erick Claessens, Jonathan Janes, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|May 9, 2006
Life-threatening hemophagocytic syndrome related to mycobacterium tuberculosisYann-Erick Claessens, Frédéric Pene, Micheline Tulliez, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 1, 2013
Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values?Camille Chenevier-Gobeaux, Eloise Trabattoni, Marie Roelens, et al.
Pageof 9